ELEVATION ONCOLOGY INC(NASDAQ:ELEV) stock News

ELEV Latest News, Press Relases and Analysis

All

Press Releases

4 months ago - By: Halper Sadeh LLC - Mentions: FLS MTWO CRKN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders

4 months ago - By: Halper Sadeh LLC - Mentions: CRKN STR VIGL

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRKN, ELEV, STR, VIGL on Behalf of Shareholders

4 months ago - By: Brodsky & Smith LLC - Mentions: CRKN STR VIGL VNOM ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)

4 months ago - By: Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of Shareholders

4 months ago - By: Kahn Swick & Foti, LLC

ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc. - ELEV

4 months ago - By: Benzinga - Mentions: ACGL TTGT MCD

This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday

4 months ago - By: Halper Sadeh LLP - Mentions: FLS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, KNW, ELEV, CRKN on Behalf of Shareholders

4 months ago - By: Brodsky & Smith LLC - Mentions: CRKN STR VIGL VNOM ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)

4 months ago - By: Halper Sadeh LLC

ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders

4 months ago - By: Elevation Oncology

Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right

5 months ago - By: Benzinga - Mentions: SSY HCTI NXL MODV ...

12 Health Care Stocks Moving In Thursday's After-Market Session

5 months ago - By: Elevation Oncology

Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

5 months ago - By: Zacks Investment Research - Mentions: ALLO AGEN ADPT

Allogene's Q1 Earnings In Line With Estimates, Sales Nil

5 months ago - By: Zacks Investment Research - Mentions: BEAM INSM ADPT

Insmed's Q1 Loss Wider Than Expected, Sales Match Estimates

5 months ago - By: Zacks Investment Research - Mentions: BEAM ADPT IOVA

Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% on '25 View Cut

5 months ago - By: Zacks Investment Research - Mentions: PRGO PBYI NTLA

Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y

5 months ago - By: Zacks Investment Research - Mentions: JAZZ PBYI NTLA

JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook

6 months ago - By: Elevation Oncology

Elevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

6 months ago - By: Yahoo Finance - Mentions: ATKR UTZ XMTR MCD ...

Here’s Why Middle Coast Investing Sold Atkore (ATKR)

7 months ago - By: Elevation Oncology

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

7 months ago - By: Elevation Oncology

Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements

8 months ago - By: Elevation Oncology

Elevation Oncology to Participate in Upcoming Investor Conferences

9 months ago - By: Elevation Oncology

Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones

10 months ago - By: Elevation Oncology

ELEVATION ONCOLOGY INC (ELEV) Stock News

ELEV Latest News, Press Relases and Analysis

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRKN, ELEV, STR, VIGL on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of Shareholders

ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc. - ELEV

This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, KNW, ELEV, CRKN on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)

ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders

Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right

12 Health Care Stocks Moving In Thursday's After-Market Session

Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

Allogene's Q1 Earnings In Line With Estimates, Sales Nil

Insmed's Q1 Loss Wider Than Expected, Sales Match Estimates

Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% on '25 View Cut

Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y

JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook

Elevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

Here’s Why Middle Coast Investing Sold Atkore (ATKR)

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology to Participate in Upcoming Investor Conferences

Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors